Lilly to sell obesity drugs directly on Hims & Hers site
Yahoo Finance · By Michael Erman ·
Nov 6 (Reuters) - Eli Lilly said on Friday it struck a deal to allow Hims & Hers Health to sell obesity drugs Zepbound and Foundayo directly on its platform...
By Michael Erman
Nov 6 (Reuters) - Eli Lilly said on Friday it struck a deal to allow Hims & Hers Health to sell obesity drugs Zepbound and Foundayo directly on its platform, sending the telehealth company's shares up more than 7% in premarket trading.
The Lilly drugs were previously available to patients on Hims & Hers only if they left the site and went to Lilly's own cash-pay platform LillyDirect.
Read the full story at Yahoo Finance · All coverage of this story